Objective: Recurrence is the main hinderance in treatment of aneurysmal bone cysts (ABCs). Therefore, several treatment modalities and adjuvant therapies have been proposed. In this study, we aim to evaluate the long‐term effectiveness of percutaneous curettage and allogenic bone grafting as a new, minimally invasive modality in treating ABCs.Methods: We performed a retrospective review of the medical records of patients diagnosed with primary ABCs at a university hospital over a 10‐year period (2000–2010). We selected all patients who were diagnosed with primary ABC in the extremities and pelvis, treated with the same surgical procedure, and were followed for at least 2 years postoperatively. All patients underwent the same procedure of percutaneous curettage and impaction of allogenic pulverized fine bone fragments (harvested from locally stored femoral heads) mixed with autologous bone marrow aspirate from the iliac bone. We reported patient's characteristics (age and gender), site and size of the lesion, presenting symptoms, Capanna classification, follow‐up duration, and post‐operative complications. Assessment of cyst healing was based on the appearance on radiographs according to the modified Neer classification.Results: Nineteen patients were included in this study; 10 patients were males and nine were females. The mean age was 9.6 years (range 3–15). The location of the lesions was as follows: femur (eight), tibia (four), pelvis (four), proximal humerus (one), distal radius (one), and calcaneus (one). The most common presenting symptom was pain in the involved area. Pathological fracture was the presenting feature in two patients. The mean follow‐up duration was 6.4 years (range 2–18). The earliest radiological sign of incorporation of the allograft was seen at 3 months after surgery. All patients showed bone remodeling and radiographic resolution (classified as either A or B on the modified Neer classification) of their cystic lesions within 6 months. No local recurrence, infection, or pathological fractures occurred during the follow‐up period.Conclusion: Percutaneous curettage and impaction of allogenic bone graft mixed with autogenic bone marrow aspirate is an efficient, minimally invasive, reproducible, and affordable procedure for the treatment of primary ABCs.
4 September 2021 in International Journal Of Clinical Practice
Purpose The purpose of this study is to determine if there is a relationship between radiological parameters measured using a plain x-ray and DXA scan score, and whether a plain x-ray can be used as surrogate imaging modality when DXA scan is not readily available. Methods We included all patients who had both a DXA scan and a pelvis x-ray done between the periods from the 1st of January 2013 until the 31st of December 2017. Bone mineral density had been measured by DXA scanning of the femoral neck and the spine. Osteoporosis was defined at T-score of any site less than −2.5. Cortical thickness indices on the AP radiograph were calculated. Results 60 patients were involved in the study and were divided into two groups. Group A had 22 patients who had a T-Score on their DEXA Scans ≤-2.5 SD the femur neck or the spine with median ± SD (-2.5±0.8, - 2.8±1.0) respectively. Group B had 38 patients who had a T-score on their DEXA Scans of >-2.5 at the femur neck and the spine with median ±SD (-1.2±0.9, -1.3±1.0) respectively, which was significantly higher than the T-score of osteoporotic (group A) patients (p=0.000) at both sites of measurement. The Cortical Thickness Index (CTI) was significantly higher (p=0.027) in group B mean ±SD (0.56±0.07), compared to (0.51± 0.08) in group A. Conclusion DXA imaging remains the gold standard for diagnosing osteoporosis and we advocate the use of CTI to detect the patients that need DXA screening in places where this modality is not readily available.
1 May 2023 in International Journal of General Medicine
Background: Flatfoot is commonly seen in the community and is a common cause of concern for parents because it could become symptomatic and lead to decreased quality of life. One of the most used management approaches is foot orthoses, although no clear evidence supports their use. We aimed to study flatfoot symptoms’ prevalence, effect on activities of daily living, and the use and effectiveness of orthoses. Methodology: This was a cross‐sectional study that included five countries from the Middle East and North Africa region (Jordan, Palestine, Syria, Egypt, and Iraq). Data were collected using an online questionnaire directed toward parents of children aged 0 to 16 from September to December 2020. The demographic factors were expressed as frequencies (percentages) using standard descriptive statistical parameters, and Pearson’s chi-square test was used to examine the relationship between study factors. Results: 1256 participants were recruited using this online survey. The majority (29.6%) of children were diagnosed in the age group of 0 to 2. The abnormal appearance of the foot was the most common (78.7%) complaint. Overall, 54.2% of patients were prescribed orthoses, of which 36.8% noticed improvement in flatness and 37.6% reported relief of symptoms. Conclusion: This study demonstrated that most participants have no or minimal symptoms and that there is a mismatch between participants’ expectations and the actual effectiveness of orthoses. Taking into consideration that there is no clear evidence to support the corrective effect of orthoses, we recommend that physicians prescribing them adhere more to their proper indications and spend more time and effort counseling and addressing patients’ and parents’ concerns about this developmental stage.
Osteoporosis, a common metabolic bone condition primarily affecting geriatrics globally, weakens bones and raises fracture risk. Prior osteoporotic fractures heighten susceptibility to further fractures, notably hip fractures, impacting outcomes post-surgical management. Analyzing this link is vital for optimizing interventions for at-risk individuals. This study investigates these associations and suggests interventions for high-risk patients. This study is a retrospective case-control analysis of 1234 patients who underwent hip fracture surgery. Hospital records from two teaching university hospitals and two major governmental hospitals in Jordan over a three-year period were reviewed. Data encompassed patient demographics, comorbidities, perioperative variables, and postoperative outcomes and complications. Of the 1234 patients, 124 (10%) had prior fragility fractures (PFF): 85 contralateral hip (68.5%), 25 distal radius (20.2%), and 18 proximal humerus fractures (14.5%). Patients with prior contralateral hip fractures had higher rates of hypertension (55.5% vs. 41.1%, p = 0.03) and dementia (3.5% vs. 2.1%, p = 0.09), with trends in diabetes (38.8% vs. 31.3%, p = 0.17) and ICU admissions (7.0% vs. 4.3%, p = 0.33) that were not statistically significant. Blood transfusion rates were comparable (35.3% vs. 33.4%, p = 0.82). Subgroup analysis showed that patients with prior proximal humerus fractures had significantly higher postoperative strong analgesic use (60.5% vs. 43.2%, p = 0.007) and increased rates of dementia compared to other subgroups. However, these findings were specific to this subgroup and cannot be generalized to all PFF patients. The one-year all-cause mortality rate was 10.6% for patients with PFF and 6.2% for those without (p = 0.22). Although not statistically significant, this trend may hold clinical relevance in understanding the prognosis of this high-risk subgroup. patients with prior contralateral hip fractures exhibited higher chances of postoperative ICU admission and increased comorbidity rates. This highlights the necessity for tailored care for this subgroup. Level III, Retrospective cohort study.